Trial Profile
Comparison of the efficacy and effect of bedtime and morning adminstration of olmesartan medoxomil/amlodipine on urinary albumin:creatinine ratio in patients with essential hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2011
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 10 Mar 2011 New trial record